Pulse Biosciences, Inc.

NASDAQ:PLSE

Medical - Instruments & Supplies

Healthcare
$45.83 +3.83%

+$0.97 today

Market cap
$3.37B
Beta
1.66
P/E (TTM)
-24.0
EPS (TTM)
-$1.10
52W Low $12.56High $28.53

Volume 0.33M

Average 0.31M

PLSE Gross Profit

Revenue minus cost of revenue: what remains to cover operating expenses after paying for what was sold.

Pulse Biosciences, Inc.NASDAQ: PLSE

Gross Profit · Q2 FY2026 · quarter ended Jun 2026

Gross profit turns positive

Q2 FY2026 gross profit was $161K, compared with -$267K a year earlier. Trailing-twelve-month gross profit was -$256K.

Context

  • Gross profit amounted to 360.0% of revenue in FY2025.
  • Gross profit increased in 2 of the last 3 fiscal years.

What to watch

Whether quarterly gross profit holds near $161K or moves back toward the trailing-twelve-month quarterly average of -$64K.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterJun 2026
$161K+419.4% QoQ
Last fiscal yearDec 2025
-$1.26M— YoY
LTMJun 2026
-$256K+4.1% YoY
Gross Profit past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+160.3%——
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Gross Profit history

USD · from the income statement

Latest · FY2025
(1.26M) USD
Year-over-year change
—

Gross Profit vs competitors

How PLSE compares with its peers on the latest reported figures

  • Peers report in different currencies, so gross profit is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of +4.1% is the 6th highest of 11, against a peer median of -1.3%.
  • Gross profit amounts to 21.6% of revenue for PLSE, versus a peer median of 81.2%.
PLSE Competitors
Gross Profit for PLSE and competitors
Company Period LTM YoY 3-year CAGR% of revenue
NVCRNovoCure LimitedLTM Mar 2026$507.13M USD+5.7%+4.9%75.2%
STAASTAAR Surgical CompanyLTM Apr 2026$221.94M USD+7.4%-6.5%76.4%
LFMDLifeMD, Inc.LTM Mar 2026$188.46M USD-8.4%+15.5%85.9%
OPKOPKO Health, Inc.LTM Mar 2026$132.08M USD-33.7%-23.7%22.7%
BBNXBeta Bionics, Inc.LTM Mar 2026$63M USD+67.3%+577.0%57.2%
NKTRNektar TherapeuticsLTM Jun 2026$54.24M USD-13.2%-7.8%99.4%
KMTSKestra Medical Technologies, Ltd.LTM Jan 2026$40.81M USD+127.1%—48.8%
IMTXImmatics N.V.LTM Mar 2026€37.3M EUR-74.1%-9.9%100.0%
ATAIAtai Beckley Inc.LTM Jun 2026$3.86M USD+123.9%+261.7%86.3%
DNTHDianthus Therapeutics, Inc.LTM Jun 2026$1.83M USD-62.3%-31.8%96.0%
PLSEPulse Biosciences, Inc.LTM Jun 2026-$256K USD+4.1%—21.6%
Peer median (excluding PLSE) —-1.3%-6.5%81.2%

Competitors are the stored peer set for PLSE. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue1.42M700K00350K
Cost of Revenue1.97M11.94M1.21M01.61M
Gross Profit(550K)(11.24M)(1.21M)0(1.26M)
Gross Margin-38.8%-1606.3%——-360.0%
Research & Development28.64M20.84M27.8M32.34M44.72M
Selling, General & Admin33.82M25.97M15.78M23.92M32.03M
Operating Expenses62.46M46.81M42.37M56.26M75.68M
Depreciation & Amortization1.15M1.36M1.21M1.18M1.07M
EBITDA(62.51M)(57.15M)(39.9M)(52.41M)(71.71M)
EBITDA Margin-4408.6%-8164.3%——-20488.6%
Operating Income(63.01M)(58.06M)(43.57M)(56.26M)(76.94M)
Operating Margin-4443.9%-8293.9%——-21982.6%
Interest Income002.46M2.67M4.21M
Interest Expense646K448K1.1M00
Other Income / Expenses(646K)(448K)1.36M2.67M4.16M
Income Before Tax(63.66M)(58.51M)(42.21M)(53.59M)(72.78M)
Pre-Tax Margin-4489.4%-8357.9%——-20794.6%
Income Tax Expense00000
Net Income(63.66M)(58.51M)(42.21M)(53.59M)(72.78M)
Net Margin-4489.4%-8357.9%——-20794.6%
EPS (Basic)(2.28)(1.72)(0.88)(0.92)(1.08)
EPS (Diluted)(2.28)(1.72)(0.88)(0.92)(1.08)
Weighted Avg Shares27.96M33.94M48.04M58.4M67.4M
Weighted Avg Shares (Diluted)27.96M33.94M48.04M58.4M67.4M

Pulse Biosciences, Inc.

NASDAQ:PLSE

Intrinsic Alpha fair value

Locked

Current Price

$45.83

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.